Globus Medical Inc

GMED:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:31 PM EST
65.89quote price arrow up+0.52 (+0.80%)
Volume
122,068
52 week range
33.41 - 68.20

...

Loading . . .

KEY STATS

  • Open65.77
  • Day High65.97
  • Day Low65.11
  • Prev Close65.36
  • 52 Week High68.20
  • 52 Week High Date01/08/21
  • 52 Week Low33.41
  • 52 Week Low Date03/16/20
  • Market Cap6,501.53M
  • Shares Out98.68M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta0.98
  • 1 Year % Change23.86

RATIOS/PROFITABILITY

  • EPS (TTM)0.92
  • P/E (TTM)71.72
  • Fwd P/E (NTM)34.19
  • EBITDA (MRQ)166.85M
  • ROE (MRQ)6.88%
  • Revenue (MRQ)767.26M
  • Gross Margin (MRQ)73.23%
  • Net Margin (MRQ)12.36%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/18/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Globus Medical Inc News

There is no recent news for this security.

Latest GMED News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches....
David Paul
Chairman
David Demski
President
Keith Pfeil
Chief Financial Officer
Daniel Scavilla
Executive Vice President
Address
2560 General Armistead Ave
Audubon, PA
19403-5214
United States